World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
28892
World Ranking
11806
National Ranking
6051

Overview

Richard B. Rothman is affiliated with the National Institute on Drug Abuse in the United States. Their work is positioned within a leading federal research institution focused on advancing understanding of drug use and its impact on health and society.

Although detailed records of recent publications, co-authors, and frequent publication venues are not provided, Rothman's professional affiliation places them within a context of extensive research on substance use, addiction, and related pharmacological studies.

There is no available information regarding specific fields or subfields of study, recent papers, or book publications under their authorship. Similarly, data on frequent collaborators or specific research topics have not been documented in the available source.

No awards or honors have been listed, and there is no indication that Richard B. Rothman is deceased. The absence of detailed data about research outputs suggests a focus on ongoing institutional research activities rather than a publicly documented publication record.

The current profile reflects Richard B. Rothman's association with a prominent research institution dedicated to drug abuse research without additional data on individual contributions or scientific impact in terms of published work, collaborative networks, or recognized fields of expertise.

Best Publications

  • Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.

    Richard B. Rothman;Michael H. Baumann;Christina M. Dersch;Dana V. Romero

  • Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist

    Bryan L. Roth;Karen Baner;Richard Westkaemper;Daniel Siebert

  • A proposal for the classification of sigma binding sites.

    Rémi Quirion;Wayne D. Bowen;Yossef Itzhak;Jean Louis Junien

  • Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.

    Richard B. Rothman;Michael H. Baumann;Jason E. Savage;Laura Rauser

  • Monoamine transporters and psychostimulant drugs.

    Richard B. Rothman;Michael H. Baumann

  • The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

    Michael H Baumann;Mario A Ayestas;John S Partilla;Jacqueline R Sink

  • Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.

    Michael H Baumann;John S Partilla;Kurt R Lehner;Eric B Thorndike

  • Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats

    William A. Carlezon;Cécile Béguin;Jennifer A. DiNieri;Michael H. Baumann

  • N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.

    Niels H Jensen;Ramona M Rodriguiz;Marc G Caron;William C Wetsel

  • 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro

    Vincent Setola;Sandra J. Hufeisen;K. Jane Grande-Allen;Ivan Vesely

  • Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice.

    J. L. Cadet;Peilin Sheng;Syed Ali;R. Rothman

  • 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings

    Michael H. Baumann;Xiaoying Wang;Richard B. Rothman

  • Probes for Narcotic Receptor Mediated Phenomena. 19. Synthesis of (+)-4-[(.alpha.R)-.alpha.-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): A Highly Selective, Nonpeptide .delta. Opioid Receptor Agonist

    Silvia N. Calderon;Richard B. Rothman;Frank Porreca;Judith L. Flippen-Anderson

  • SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist.

    E J Bilsky;S N Calderon;T Wang;R N Bernstein

  • An Opioid Agonist that Does Not Induce μ-Opioid Receptor—Arrestin Interactions or Receptor Internalization

    Chad E Groer;Kevin Tidgewell;Robert A. Moyer;Wayne W Harding

  • Dose-related neurobehavioral effects of chronic cocaine use.

    Karen I. Bolla;Richard Rothman;Jean Lud Cadet

  • Distribution of opiate receptor subtypes and enkephalin and dynorphin immunoreactivity in the hippocampus of squirrel, guinea pig, rat, and hamster

    Stafford McLean;Richard B. Rothman;Arthur E. Jacobson;Kenner C. Rice

  • N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').

    Michael H Baumann;Robert D Clark;Allison G Budzynski;John S Partilla

  • Autoradiographic localization of μ- and δ-opiate receptors in the forebrain of the rat

    Stafford McLean;Richard B. Rothman;Miles Herkenham

  • Aminorex, Fenfluramine, and Chlorphentermine Are Serotonin Transporter Substrates Implications for Primary Pulmonary Hypertension

    Richard B. Rothman;Mario A. Ayestas;Christina M. Dersch;Michael H. Baumann

Frequent Co-Authors

Kenner C. Rice
Kenner C. Rice National Institutes of Health
Michael H. Baumann
Michael H. Baumann National Institute on Drug Abuse
Arthur E. Jacobson
Arthur E. Jacobson National Institutes of Health
Frank Porreca
Frank Porreca University of Arizona
F. Ivy Carroll
F. Ivy Carroll Research Triangle Park Foundation
Jean Lud Cadet
Jean Lud Cadet National Institute on Drug Abuse
Judith L. Flippen-Anderson
Judith L. Flippen-Anderson United States Naval Research Laboratory
Jeffrey R. Deschamps
Jeffrey R. Deschamps United States Naval Research Laboratory
Syed F. Ali
Syed F. Ali National Center for Toxicological Research
Candace B. Pert
Candace B. Pert National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA can also open doors to a variety of respected online health degrees and career paths, each tailored to different interests and timelines. For nurses aiming to lead with specialized expertise, programs like the easiest dnp program reddit provide valuable insights into pursuing a Doctor of Nursing Practice with flexible, less intensive study options.

If you’re seeking a faster entry into healthcare, consider the lpn program choices available online. These streamlined programs make it possible to quickly earn qualifications and start contributing on the clinical frontlines.

For those drawn to mental health, nurse practitioners can advance their credentials via psych np programs that combine psychiatric specialization with online flexibility, responding to the rising demand for mental health professionals.

Alternatively, a management role may appeal to those interested in the business side of healthcare. The best online mha programs deliver affordable routes to leadership in hospitals and healthcare systems. These diverse pathways make it easier than ever to find a healthcare career that fits your goals and lifestyle.

Best Scientists Citing Richard B. Rothman

Trending Scientists